Pivotal Therapeutics Inc.

OTCPK:PVTT.F Stock Report

Market Cap: US$172.4k

Pivotal Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Rachelle MacSweeney

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure12yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure12.7yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Rachelle MacSweeney

12yrs

Tenure

CA$314,630

Compensation

Mrs. Rachelle MacSweeney, B.Sc, MBA is the Co-Founder of Pivotal Therapeutics Inc. and has been its President since June 2011 and Chief Executive Officer since August 03, 2016. Mrs. MacSweeney served as Ch...


Board Members

NamePositionTenureCompensationOwnership
Rachelle MacSweeney
Co-Founder12.7yrsCA$314.63kno data
George Jackowski
Co-Founder12.7yrsCA$360.00kno data
John Gebhardt
Independent Non-Executive Chairman11.6yrsCA$30.21kno data

12.7yrs

Average Tenure

Experienced Board: PVTT.F's board of directors are seasoned and experienced ( 12.7 years average tenure).